Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models-Reference-Cited by-同舟云学术

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models

Published:2018-11-26 Issue:5 Volume:34 Page:783-796
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:Journal of Bone and Mineral Research

Author:

Paton‐Hough Julia¹²,Tazzyman Simon¹²,Evans Holly¹²,Lath Darren¹²,Down Jenny M¹²,Green Alanna C¹²,Snowden John A³,Chantry Andrew D¹²³,Lawson Michelle A¹²

Affiliation:

1. Sheffield Myeloma Research TeamDepartment of Oncology and Metabolism, Medical SchoolUniversity of SheffieldSheffieldUK

2. Mellanby Centre for Bone ResearchUniversity of Sheffield Medical School, University of SheffieldSheffieldUK

3. Department of HaematologySheffield Teaching Hospitals NHS Foundation TrustRoyal Hallamshire HospitalSheffieldUK

Funder

Bloodwise

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.3606

Reference77 articles.

1. Malignant bone pain: pathophysiology and treatment

2. Pathogenesis of myeloma bone disease

3. Fracture Risk With Multiple Myeloma: A Population-Based Study

4. Pathologic fractures correlate with reduced survival in patients with malignant bone disease

5. Immunocytochemistry reveals RANKL expression of myeloma cells

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease;JBMR Plus;2024-07-12

2. Phenolic acids prevent sex-steroid deficiency-induced bone loss and bone marrow adipogenesis in mice;The Journal of Nutritional Biochemistry;2024-05

3. The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease;Nature Communications;2024-03-19

4. Expression of the Purinergic P2X7 Receptor in Murine MOPC315.BM Myeloma Cells;Receptors;2023-09-07

5. Novel insights on the effect of sclerostin on bone and other organs;Journal of Endocrinology;2023-02-21